Limfangitis

01Pathophysiology

Lymphangitis is an infection and inflammation of the lymphatic channels, almost always resulting from a bacterial pathogen entering through a disruption in the skin barrier. The most frequent culprit is Group A beta-hemolytic Streptococcus (Streptococcus pyogenes), followed by Staphylococcus aureus.

The sequence begins at the portal of entry, which can be as subtle as a small scratch, insect bite, or interdigital tinea pedis. Once bacteria breach the epidermis, they invade the dermal lymphatic vessels rather than spreading diffusely through subcutaneous tissue (which would instead produce cellulitis). Within the lymphatic channels, the organisms trigger an intense acute inflammatory response. Neutrophils infiltrate the vessel walls and perilymphatic soft tissue, causing the walls of the lymphatic channels to become edematous, erythematous, and painful. This inflammation tracks along the anatomical course of the lymphatic drainage, which is why the hallmark finding is a visible red streak following the path of lymphatic vessels from the site of inoculation toward the regional lymph node basin.

As the infection ascends through the lymphatic chain, it reaches the regional lymph nodes, producing reactive lymphadenitis. The nodes become enlarged, warm, and tender because they are actively filtering and responding to the bacterial load. If the infection overwhelms the lymph node barrier, organisms can spill into the bloodstream, resulting in bacteremia and sepsis. This is why lymphangitis is considered a clinical warning sign of potential systemic spread, and prompt antibiotic therapy is critical.

In patients with chronic or recurrent lymphangitis, repeated episodes of lymphatic inflammation can damage the vessel walls and impair lymphatic drainage. Over time, this leads to secondary lymphedema, which ironically predisposes the patient to further episodes of infection, creating a self-perpetuating cycle.

02Classification and Clinical Manifestation

A high-yield distinction for exam purposes: acute bacterial lymphangitis produces a continuous red streak, while nodular (sporotrichoid) lymphangitis produces a chain of discrete nodules along the lymphatic drainage pathway. If the vignette mentions a gardener, rose thorn prick, or fish tank exposure with nodules ascending the forearm, think Sporothrix or Mycobacterium marinum, not typical GAS lymphangitis.

03Diagnostic Workup

Lymphangitis is fundamentally a clinical diagnosis. The combination of a visible portal of entry plus linear erythematous streaking extending toward regional lymph nodes is essentially pathognomonic. No lab test or imaging study is needed to make the diagnosis in a straightforward presentation.

The reason we order a CBC is not to confirm the diagnosis but to gauge the severity of the systemic inflammatory response. A markedly elevated WBC with bandemia raises concern for progression toward sepsis. Blood cultures should be drawn before starting antibiotics in any patient with high fever, rigors, tachycardia, or hemodynamic instability, because a positive result changes both the antibiotic regimen and the duration of therapy.

Wound cultures are most useful when the patient fails to improve on empiric therapy or when there is concern for resistant organisms (e.g., MRSA). In routine cases of uncomplicated lymphangitis that respond quickly to empiric antibiotics, wound cultures are not always necessary.

When the presentation is nodular rather than linear, a tissue biopsy with special cultures (fungal and acid-fast in addition to routine bacterial) becomes essential because the differential includes organisms like Sporothrix schenckii and Mycobacterium marinum that require entirely different treatment regimens.

04Management and Treatment

Acute stabilization begins with assessing for sepsis. If the patient has systemic inflammatory response criteria (fever, tachycardia, hypotension, altered mental status), the immediate priorities are IV fluid resuscitation, obtaining blood cultures, and initiating broad-spectrum IV antibiotics. The "next best step" in a vignette describing a toxic-appearing patient with red streaking and high fever is always IV antibiotics, not oral therapy and outpatient follow-up.

For uncomplicated outpatient cases, the cornerstone of treatment is an oral antibiotic with gram-positive coverage. Cephalexin and dicloxacillin are both first-line choices. Elevation of the affected limb reduces edema and promotes lymphatic drainage, and warm compresses provide symptomatic relief and may enhance local perfusion to aid antibiotic delivery. Patients should be counseled to draw a line at the leading edge of the erythematous streak with a skin marker so they can objectively monitor whether the infection is progressing or regressing on therapy.

For patients with recurrent episodes, particularly those with underlying lymphedema, long-term suppressive antibiotic prophylaxis may be warranted. A common regimen is penicillin V 250 to 500 mg PO BID or intramuscular benzathine penicillin G every 3 to 4 weeks.

Contraindications and cautions: In patients with true anaphylaxis to penicillin, avoid all beta-lactams and use clindamycin or a fluoroquinolone. In patients with renal impairment, dose-adjust vancomycin carefully and follow trough levels. TMP-SMX should be used with caution in patients on ACE inhibitors or potassium-sparing diuretics due to the risk of hyperkalemia.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most common way students miss lymphangitis questions is by confusing it with cellulitis. Both are bacterial skin and soft tissue infections caused by the same organisms, and both can follow a break in the skin. The critical discriminator is the pattern of erythema: cellulitis produces an area of diffuse, spreading redness, while lymphangitis produces a clearly defined linear red streak tracking along the lymphatic drainage pathway toward a regional lymph node basin. If the vignette describes a red line extending from a wound toward the axilla or inguinal region, the answer is lymphangitis, not cellulitis, even though both are treated with similar antibiotics.

Another common trap involves superficial thrombophlebitis. A vignette may describe a linear, tender, red cord on the arm or leg, which can look identical to lymphangitis on first read. The key is to look for contextual clues: thrombophlebitis is associated with IV catheter use, varicose veins, or hypercoagulable states and follows a venous course without lymphadenopathy. Lymphangitis follows a lymphatic course, originates from a wound, and is accompanied by tender lymphadenopathy.

Students also occasionally mistake the nodular (sporotrichoid) pattern for typical bacterial lymphangitis. If the vignette describes a chain of nodules ascending the forearm in a gardener or aquarium hobbyist, the answer is sporotrichoid lymphangitis (most likely Sporothrix schenckii or Mycobacterium marinum), not standard GAS lymphangitis. The treatment is antifungal (itraconazole) or anti-mycobacterial therapy, not cephalexin.

Finally, recognize that lymphangitis is a clinical warning sign of impending bacteremia. If the vignette presents a patient with red streaking plus systemic toxicity (high fever, rigors, hypotension), the expected next step is blood cultures and IV antibiotics, not oral therapy with outpatient follow-up. Underestimating the severity of lymphangitis with systemic signs is a frequent test-taking error. The core competency being tested is your ability to recognize lymphangitis by its classic linear pattern, differentiate it from look-alikes, and appropriately escalate management when systemic signs are present.